Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1432]

NICE recommends vemurafenib for advanced malignant melanoma and a mutated BRAF gene

NICE recommends vemurafenib for advanced malignant melanoma and a mutated BRAF gene

Positive NICE decision on ipilimumab, the first treatment for advanced melanoma to be licensed in the UK for over 30 years

Positive NICE decision on ipilimumab, the first treatment for advanced melanoma to be licensed in the UK for over...

NCRI 2012: Highlights from Monday 5 November

NCRI 2012: Highlights from Monday 5 November

NCRI 2012: Three-in-one 'super molecule' could detect cancer early, help destroy tumours and monitor treatment

NCRI 2012: Three-in-one 'super molecule' could detect cancer early, help destroy tumours and monitor treatment

NICE gives go ahead to ipilimumab for advanced melanoma

NICE gives go ahead to ipilimumab for advanced melanoma

Melanoma development in people with red hair and fair skin does not depend solely on ultraviolet radiation

Melanoma development in people with red hair and fair skin does not depend solely on ultraviolet radiation

Survivors of certain cancers reported poor health-related quality of life years after diagnosis

Survivors of certain cancers reported poor health-related quality of life years after diagnosis

Researchers identify unique immune gene signature across thousands of patients' solid tumours

Researchers identify unique immune gene signature across thousands of patients' solid tumours

Skin rash predicts survival benefit from latest lung cancer drug

Skin rash predicts survival benefit from latest lung cancer drug

Melanomas become resistant to therapy through inflammation-induced dedifferentiation

Melanomas become resistant to therapy through inflammation-induced dedifferentiation

More from ecancer